- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04883476
Chronic Low Back Pain and Neck Pain Prospective Study
A Prospective Study to Identify New "Omics" and Imaging Biomarkers of Chronic/Persistent Neck and Low Back Pain
This prospective observation multifaceted study aims:
- To perform a large prospective study and identify multiple "omics" biomarkers in chronic low back pain
- To validate identified biomarkers for progression of acute to chronic low back pain
- To validate identified biomarkers and test their heritability/validity in additional cohorts
- To identify pathways and relevant individual variations for generation, propagation and subsidence of pain
- To identify new imaging biomarkers related to chronic low back pain
- To develop a registry of neck and low back pain subjects to help monitor the health-care management and utility to improve protocols and patient outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- Queen Mary Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Neck and/or low back pain
- New cases*
- Males and females
- 18 years or older
- Willing to participate in the study short- and long-term
Exclusion Criteria:
- Previous spine surgery
- Cognitively impaired
- Drug addiction
- Incarceration (prisoner)
- History of infections, tumors, chronic inflammation (e.g. rheumatoid arthritis, ankylosing spondylitis)
- Congenital/syndromal
- Pregnant females
- Diagnosed psychological impairment
- Inability to read or write
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Chronic Low Back Pain and Neck Pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Radiographic assessment
Time Frame: Change up to 60-months follow-up
|
assess the subjects' standing X-ray of the whole spine (AP and lateral) for the presence and extent of atherosclerosis, endplate thickening (sclerosis), vertebral osteophytes, limbus vertebrae, presence and categorization of vertebral subluxation (spondylolisthesis), additional spine-related deformities, spinal canal and vertebral body/foraminal dimensions, and static/dynamic spinal motion parameters and alignments.
This will be done at interval follow-ups
|
Change up to 60-months follow-up
|
MRI assessment
Time Frame: Change up to 60-months follow-up
|
MRI: Sagittal T2W MRI whole spine and axial T1W MRI of lumbar spine will be assessed in all subjects. The radiographic events/outcomes of interest entailed the presence and extent of disc degeneration, disc bulges/herniations, Schmorl's nodes (endplate irregularities), high-intensity zones (HIZ), and bone marrow signal changes involving the endplate. Interval assessments will be made. |
Change up to 60-months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oswestry Disability index
Time Frame: Change to 60-months follow-up
|
Questionnaire assessment: ODI is based on a 0-5 scale with 5 representing greatest disability.
The index is calculated by dividing the summed score by the total possible score then multiplied by 100 as a percentage.
|
Change to 60-months follow-up
|
Neck disability index
Time Frame: Change to 60-months follow-up
|
Questionnaire assessment: NDI assesses neck pain related disability.
There are 10 items scored from 0-5 with maximum score of 50 indicating most severe pain.
|
Change to 60-months follow-up
|
Neck pain disability scale
Time Frame: Change to 60-months follow-up
|
Questionnaire assessment: NPAD is a composite score of 20 items.
Each score ranges from 0-5 with maximum score of 100 indicating maximal pain.
|
Change to 60-months follow-up
|
Depression-Anxiety Stress Scale
Time Frame: Change to 60-months follow-up
|
Questionnaire assessment: DASS assesses symptoms based on a 4-point scale with subscales for depression, anxiety and stress.
A range of 0-42 can be used with a higher score indicating worse severity.
|
Change to 60-months follow-up
|
SF-36
Time Frame: Change to 60-months follow-up
|
Questionnaire assessment: eight scaled score with weighted sums.
Transformed to 0-100 scale, lower score means more disability.
|
Change to 60-months follow-up
|
VAS
Time Frame: Change to 60-months follow-up
|
Questionnaire assessment for pain score.
0-10 with 10 being most severe.
|
Change to 60-months follow-up
|
Cholesterol assessment
Time Frame: Change to 60-months follow-up
|
low density lipoprotein (LDL), high density lipoprotein (HDL), cholesterol counts, triglycerides
|
Change to 60-months follow-up
|
ESR
Time Frame: Change to 60-months follow-up
|
Inflammatory marker via blood test
|
Change to 60-months follow-up
|
C-reactive protein
Time Frame: Change to 60-months follow-up
|
Inflammatory marker via blood test
|
Change to 60-months follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dr. Jason Cheung, The University of Hong Kong/ Queen Mary Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Study Protocol v. 1.0
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Low Back Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Iran University of Medical SciencesNot yet recruitingLow Back Pain | Chronic Low-back Pain | Chronic Non-specific Low Back Pain | Cupping Therapy
-
Federal University of Minas GeraisRecruitingBack Pain | Low Back Pain | Chronic Low-back Pain | Back Pain Lower Back ChronicBrazil
-
University of Colorado, BoulderNational Institutes of Health (NIH); Radiological Society of North America; Psychophysiologic... and other collaboratorsCompletedChronic Pain | Back Pain Lower Back Chronic | Back Pain, LowUnited States
-
Federal University of ParaíbaCompletedChronic Low Back Pain | Nonspecific Chronic Low Back Pain
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
Presidio Medical, IncRecruitingChronic Pain | Chronic Low-back PainAustralia
-
Spaulding Rehabilitation HospitalHighland Instruments, Inc.Active, not recruitingChronic Pain | Chronic Low Back PainUnited States
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)Active, not recruiting
-
Dan RhonNational Center for Complementary and Integrative Health (NCCIH); 59th Medical... and other collaboratorsRecruitingLow Back Pain | Chronic Pain | Surgery | Back Pain Lower Back Chronic | Back Pain, LowUnited States
Clinical Trials on Observation study only
-
Sun Yat-sen UniversityEssilor InternationalCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruitingMolar Incisor HypomineralisationUnited Kingdom
-
Queen Mary University of LondonRecruiting
-
University of PennsylvaniaCompletedRespiratory Failure | CoronavirusUnited States
-
Abramson Cancer Center at Penn MedicineEnrolling by invitationLeukemia, Myeloid, Acute | Cardiotoxicity | Leukemia, Lymphoid, AcuteUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Recruiting
-
Pamela Youde Nethersole Eastern HospitalRecruiting
-
Queen Mary University of LondonRecruitingMyocardial Infarction | Coronary Microvascular Disease | GenderUnited Kingdom
-
Temple UniversityJanssen Services, LLCCompleted
-
University of PennsylvaniaCompletedFrontotemporal Degeneration | Multiple System Atrophy | Progressive Supranuclear PalsyUnited States